Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-07 08:00 am Purchase | 13G | AMALGAMATED FINL CORP AMAL | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,963,108 6.46% | 342,477 (+21.13%) | View |
2024-02-07 07:59 am Purchase | 13G | GUILD HLDGS CO GHLD | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,185,815 5.71% | 24,562 (+2.12%) | View |
2024-02-07 07:58 am Unchanged | 13G | EDIFY ACQUISITION CORP EAC | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0% | 0 (Unchanged) | View |
2024-02-07 07:56 am Purchase | 13G | SUTRO BIOPHARMA INC STRO | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,467,796 7.33% | 918,476 (+25.88%) | View |
2024-02-07 07:56 am Sale | 13G | IMMUNOGEN INC IMGN | ADAGE CAPITAL PARTNERS GP L.L.C. | 971,928 0.35% | -10,147,072 (-91.26%) | View |
2024-02-07 07:56 am Sale | 13G | NKARTA INC NKTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,450,000 7.03% | -250,000 (-6.76%) | View |
2024-02-07 07:55 am Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,925,094 4.54% | 323,535 (+12.44%) | View |
2024-02-07 07:54 am Unchanged | 13G | SOUTHLAND HLDGS INC SLND | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0% | 0 (Unchanged) | View |
2024-02-07 07:54 am Purchase | 13G | EYEPOINT PHARMACEUTICALS, INC. EYPT | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,466,420 9.15% | 2,516,420 (+129.05%) | View |
2024-02-07 07:54 am Purchase | 13G | AURA BIOSCIENCES INC AURA | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,225,000 8.61% | 2,092,261 (+98.10%) | View |
2024-02-07 07:51 am Purchase | 13G | MEIRAGTX HLDGS PLC MGTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 5,291,618 8.32% | 2,185,818 (+70.38%) | View |
2024-02-07 07:50 am Unchanged | 13G | CONSTELLATIONS ACQUISITION COR CSTA | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0% | 0 (Unchanged) | View |
2024-02-07 07:50 am Purchase | 13G | MAMMOTH ENERGY SVCS INC TUSK | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,275,000 8.92% | 1,147,732 (+36.70%) | View |
2024-02-07 07:46 am Sale | 13G | ESGEN ACQ.CORP ESAC | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0% | -1,620,000 (Position Closed) | View |
2024-02-07 07:46 am Purchase | 13G | PRAXIS PRECISION MEDICINES INC PRAX | ADAGE CAPITAL PARTNERS GP L.L.C. | 738,666 8.4% | 738,666 (New Position) | View |
2024-02-07 07:46 am Purchase | 13G | INOZYME PHARMA INC INZY | ADAGE CAPITAL PARTNERS GP L.L.C. | 5,537,500 8.97% | 2,437,362 (+78.62%) | View |
2024-02-07 07:45 am Sale | 13G | TSCAN THERAPEUTICS INC TCRX | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,900,000 8.96% | -100,000 (-2.50%) | View |
2024-02-07 07:45 am Sale | 13G | RAIN ONCOLOGY INC. RAIN | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0% | -1,523,282 (Position Closed) | View |
2024-02-07 07:44 am Sale | 13G | FULCRUM THERAPEUTICS INC FULC | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,506,422 2.44% | -1,964,125 (-56.59%) | View |
2024-02-07 07:43 am Sale | 13G | ADAM NAT RES FD INC PEO | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0% | -1,308,791 (Position Closed) | View |